Abstract

Cervical cancer in Indonesia ranks first, 65% of the patient's condition is in an advanced stage. In research in thirteen anatomical pathology laboratories in Indonesia, the frequency of cervical cancer patients was around 18.5%. This community service aims to: (1) provide communication, education and information (IEC) about cervical cancer and the benefits of IVA Test; (2) conduct IVA Test; (3) measure WUS's knowledge about cervical cancer and IVA test. Performed at the maternity clinic, namely SAM maternity clinic (20 people) and Sari (20 people). Data analysis using dependent t test. The results of the activity were data from 26-30 years old (40%), Batak tribes (13%), Islamic religion (95%), first marriage (77.5%), high school / diploma / undergraduate education (80%), IRT (77.5 %), the work of husband's employee (52.5%), first age married 26-30 years (40%) and not smoking (80%); using injection contraception (42.5%); the obstetric history of the majority of WUS giving birth twice (42.5%) , never checked (80%), no brother is sick (75%), breast cancer (10%), not much vaginal discharge (65%), no pain under the abdomen (70%), no bleeding during intercourse (90%) and did not experience irregular menstruation (55%); results of IVA WUS Test were negative (80%), inflammation (17.5) and positive (2.5); WUS knowledge before being given Information Education Communication (IEC) about cervical cancer and the IVA Test averages = 13.58, SD = 3.012 and after being given health education on average = 14.30, SD = 3.275. The results of statistical tests obtained different mean = 0.725 and P value = 0.016, it can be concluded that there was a significant effect of IEC on WUS knowledge about cervical cancer and IVA Test. Keywords: Cervical cancer, fertile age women (WUS), IVA Test

Highlights

  • Kanker rahim di Indonesia menduduki peringkat pertama, 65% kondisi pasiennya dalam stadium lanjut

  • Cervical cancer in Indonesia ranks first, 65% of the patient's condition is in an advanced stage

  • Undergraduate education (80%), IRT (77.5 %), the work of husband's employee (52.5%), first age married 26-30 years (40%) and not smoking (80%); using injection contraception (42.5%); the obstetric history of the majority of Wanita Usia Subur (WUS) giving birth twice (42.5%), never checked (80%), no brother is sick (75%), breast cancer (10%), not much vaginal discharge (65%), no pain under the abdomen (70%), no bleeding during intercourse (90%) and did not experience irregular menstruation (55%); results of IVA WUS Test were negative (80%), inflammation

Read more

Summary

DI KLINIK BERSALIN KOTA MEDAN

Kanker rahim di Indonesia menduduki peringkat pertama, 65% kondisi pasiennya dalam stadium lanjut. Hasil kegiatan diperoleh data berusia 26-30 tahun (40%),suku batak (13%),agama islam (95%),menikah pertama kali (77.5%),pendidikan. SMA/diploma/sarjana (80%),IRT (77.5%),pekerjaan suami karyawan (52.5%),umur pertama menikah 26-30 tahun(40%) dan tidak merokok (80 %);menggunakan alat kontrasepsi suntik (42.5%);riwayat obstetri mayoritas. WUS melahirkan 2 kali (42.5%),tidak pernah periksa (80%),tidak ada saudara yang sakit(75%),kanker payudara (10%),tidak banyak keputihan (65%),tidak ada sakit di bawah perut(70%), tidak ada perdarahan saat bersenggama (90%) dan tidak mengalami haid tidak teratur (55%);hasil IVA Test WUS negatif(80%),radang (17,5) dan positif (2.5);pengetahuan WUS sebelum diberi Komunikasi Edukasi Informasi (KIE) tentang kanker serviks dan IVA Test rata–rata= 13.58,SD =3.012 dan sesudah diberi pendidikan kesehatan rata –rata= 14.30, SD = 3.275. Hasil uji statistik diperoleh beda mean = 0.725 dan nilai P=0,016,maka dapat disimpulkan ada pengaruh yang signifikan KIE terhadap pengetahuan WUS tentang kanker serviks dan IVA Test

Pemeriksaan skrining kanker serviks bisa dilakukan dengan cara Inspeksi Visual
Metode pemeriksaan
Permasalahan Mitra
METODE PELAKSANAAN
Analisis Univariat
Akan tetapi manfaat IVA test masih ditemukan
Daftar Pustaka
Findings
Kesimpulan dan Saran
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call